[Clinical significance of autologous transplantation with hematopoietic stem cells in leukemia and solid tumors].
Autologous Transplantation of hematopoietic tissue with frozen hematopoietic stem cells is increasingly used for leukemias and lymphomas, but also for some solid tumors. In the past, autotransplants have been performed with bone marrow as the source of hematopoietic stem cells. Circulating, blood derived hematopoietic stem cells, however, allow safe engraftment of all cell lines after supralethal chemo-radiotherapy. This survey describes the role of autologous stem cell transplantation in disorders that are currently in the center of clinical and scientific interest. This estimation is based on the proportion of protocols dealing with, and centering on, autologous stem cell transplantation in the context of treatment for leukemias and solid tumors ("Oncodisc", "PDQ").
Hinterberger
W
W
Ludwig-Boltzmann-Institut für Stammzelltransplantation, Wien.
Adler
V
V
Bauer
K
K
Haberhauer
G
G
Habertheuer
K H
KH
Höniger
S
S
Huber
K
K
Kier
P
P
Kittel
E
E
Ruckser
R
R
D003131:Combined Modality Therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D012074:Remission Induction; D014182:Transplantation, Autologous
Die klinische Bedeutung der autologen Transplantation mit hämatopoetischen Stammzellen bei Leukämien und soliden Tumoren.